Alp Invest Partners B.V. Essa Pharma Inc. Transaction History

Alp Invest Partners B.V.

  • $140 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 10, 2022
SELL
$1.75 - $3.44 $116,306 - $228,625
-66,461 Reduced 62.47%
39,930 $73,000
Q1 2022

May 13, 2022
BUY
$6.18 - $14.44 $657,496 - $1.54 Million
106,391 New
106,391 $657,000
Q4 2021

Feb 11, 2022
SELL
$7.8 - $14.38 $168,838 - $311,269
-21,646 Closed
0 $0
Q2 2021

Aug 12, 2021
BUY
$24.17 - $34.28 $523,183 - $742,024
21,646 New
21,646 $618,000

Others Institutions Holding EPIX

# of Institutions
35
Shares Held
35.1M
Call Options Held
15.8K
Put Options Held
21K
View Full List

About ESSA Pharma Inc.

EPIX Quotes by TradingView
  • Ticker EPIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 44,073,100
  • Market Cap $75.4M
  • Description
  • ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses on developing novel and proprietary therapies for the treatment of prostate cancer. It develops EPI-7386, an oral candidate that is in a Phase I clinical study for the treatment of patients with metastatic castration-resistant prostate cancer. The company has collaboration agreem...
More about EPIX
Track This Portfolio

Track Alp Invest Partners B.V. Portfolio

Follow Alp Invest Partners B.V. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alp Invest Partners B.V., based on Form 13F filings with the SEC.

News

Stay updated on Alp Invest Partners B.V. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email